Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype

被引:134
作者
Garcia, Stephane
Dales, Jean-Philippe
Charafe-Jauffret, Emmanuelle
Carpentier-Meunier, Severine
Andrac-Meyer, Lucile
Jacquemier, Jocelyne
Andonian, Claudine
Lavaut, Marie-Noelle
Allasia, Claude
Bonnier, Pascal
Charpin, Colette
机构
[1] Ctr Hosp Univ Nord, Dept Pathol, F-13916 Marseille, France
[2] Inst J Paoli I Calmettes, Dept Biopathol, F-13005 Marseille, France
[3] Fac Med Timone, F-13005 Marseille, France
[4] Ctr Hostp Liberal Beauregard, Hop Conception, Dept Gynecol & Breast Oncol, F-13011 Marseille, France
关键词
cancer spreading; angiogenesis; c-Met; signal transducers; TMAs; image analysis;
D O I
10.1016/j.humpath.2006.11.015
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Genomic studies have led to new taxonomic classifications of breast carcinomas. Proteomic investigations using tissue microarrays have yielded complementary results and are useful in identifying potential molecular targets for specific therapies. Searching for new drug targets is particularly important for tumors of poor prognosis, such as breast tumors that lack estrogen receptors and HER2 amplification; in these tumors, certain molecules probably play a significant role in tumor spreading through the stromal microvasculature. We investigated 930 breast carcinomas categorized according to patients' survival (range of follow-up 4-10 years; median follow-up 6.5 years) using (1) automated immunohistochemical procedures (Ventana, Cedex, France) with tissue microarrays (Alphelys, Plaisir, France) and (2) quantification of immunoprecipitates assessed by automated image analysis densitometry (SAMBA, Meylan, France). Expression of c-Met and CD146 and that of signaling transducers PI3K, FAK, and FYN were compared in living and deceased patients. Expression of some proteins recently reported to be characteristic of basal cell carcinomas was also assessed, namely, CK5-6, caveolin-1, carbonic anhydrase IX, p63, and CD117; these also constitute potential targets for therapies for aggressive tumors. Overexpression of these proteins was observed in deceased or metastatic patients (P <.01 to P <.00001), particularly node-negative patients (except for FYN, p63, and CD146). c-Met and CD146 are involved in tumor spreading, and our results suggest that they probably play an important role in patients' death, along with other proteins involved in hypoxia (carbonic anhydrase IX) and other cell functions or structures (caveolin-1, CD 117, CK5-6, and p63) that are expressed in an aggressive subtype of basal cell carcinoma for which no specific therapy is available. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:830 / 841
页数:12
相关论文
共 36 条
[1]   Outside-in signaling pathway linked to CD146 engagement in human endothelial cells [J].
Anfosso, F ;
Bardin, N ;
Vivier, E ;
Sabatier, F ;
Sampol, J ;
Dignat-George, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1564-1569
[2]  
Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO
[3]  
2-E
[4]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[5]  
Camp RL, 2003, CANCER RES, V63, P1445
[6]   Automated subcellular localization and quantification of protein expression in tissue microarrays [J].
Camp, RL ;
Chung, GG ;
Rimm, DL .
NATURE MEDICINE, 2002, 8 (11) :1323-1327
[7]   Gene expression profiling of breast cell lines identifies potential new basal markers [J].
Charafe-Jauffret, E ;
Ginestier, C ;
Monville, F ;
Finetti, P ;
Adélaïde, J ;
Cervera, N ;
Fekairi, S ;
Xerri, L ;
Jacquemier, J ;
Birnbaum, D ;
Bertucci, F .
ONCOGENE, 2006, 25 (15) :2273-2284
[8]   Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays [J].
Charpin, C ;
Dales, JP ;
Garcia, S ;
Carpentier, S ;
Djemli, A ;
Andrac, L ;
Lavaut, MN ;
Allasia, C ;
Bonnier, P .
CLINICAL CANCER RESEARCH, 2004, 10 (17) :5815-5819
[9]   Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas [J].
Charpin, C ;
Garcia, S ;
Bouvier, C ;
Devictor, B ;
Andrac, L ;
Choux, R ;
Lavaut, MN ;
Allasia, C .
HUMAN PATHOLOGY, 1997, 28 (03) :289-296
[10]   QUANTITATIVE IMMUNOCYTOCHEMICAL ASSAYS OF P-GLYCOPROTEIN IN BREAST CARCINOMAS - CORRELATION TO MESSENGER-RNA EXPRESSION AND TO IMMUNOHISTOCHEMICAL PROGNOSTIC INDICATORS [J].
CHARPIN, C ;
VIELH, P ;
DUFFAUD, F ;
DEVICTOR, B ;
ANDRAC, L ;
LAVAUT, MN ;
ALLASIA, C ;
HORSCHOWSKI, N ;
PIANA, L .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (20) :1539-1545